Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study

被引：0
|
作者：
J. C. Bertoglio
M. Baumgartner
R. Palma
E. Ciampi
C. Carcamo
D. D. Cáceres
G. Acosta-Jamett
J. L. Hancke
R. A. Burgos
机构：
[1] Instituto de Medicina,Departamento de Neurología
[2] Universidad Austral de Chile,undefined
[3] Hospital Regional de Valdivia,undefined
[4] Centro de Esclerosis Multiple,undefined
[5] Facultad de Medicina,undefined
[6] Pontificia Universidad Católica,undefined
[7] Programa de Salud Ambiental,undefined
[8] Escuela de Salud Pública,undefined
[9] Facultad de Medicina,undefined
[10] Universidad de Chile,undefined
[11] Instituto de Medicina Preventiva Veterinaria y Programa de Investigación Aplicada en Fauna Silvestre,undefined
[12] Facultad de Ciencias Veterinarias,undefined
[13] Universidad Austral de Chile,undefined
[14] Instituto de Farmacología,undefined
[15] Facultad de Ciencias Veterinarias,undefined
[16] Universidad Austral de Chile,undefined
来源：
BMC Neurology | / 16卷
关键词：
Fatigue; Multiple sclerosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study
    Bertoglio, J. C.
    Baumgartner, M.
    Palma, R.
    Ciampi, E.
    Carcamo, C.
    Caceres, D. D.
    Acosta-Jamett, G.
    Hancke, J. L.
    Burgos, R. A.
    BMC NEUROLOGY, 2016, 16
  • [2] Acyclovir treatment of relapsing-remitting multiple sclerosis - A randomized, placebo-controlled, double-blind study
    Lycke, J
    Svennerholm, B
    Hjelmquist, E
    Frisen, L
    Badr, G
    Andersson, M
    Vahlne, A
    Andersen, O
    JOURNAL OF NEUROLOGY, 1996, 243 (03) : 214 - 224
  • [3] A double-blind, placebo-controlled, multicentre study to evaluate dirucotide in relapsing-remitting multiple sclerosis
    Selmaj, K.
    Verco, T.
    Ossanna, M.
    Nilsson, M.
    Ferenczi, L.
    Chappell, A.
    Arfors, L.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S235 - S235
  • [4] A double-blind, placebo-controlled, randomized trial of cladribine in relapsing-remitting multiple sclerosis
    Romine, JS
    Sipe, JC
    Koziol, JA
    Zyroff, J
    Beutler, E
    PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1999, 111 (01) : 35 - 44
  • [5] Efficacy and Safety of Tabalumab in Patients with Relapsing-Remitting Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study
    Silk, Maria
    Nantz, Eric
    NEUROLOGY, 2018, 90
  • [6] A placebo-controlled, randomized, double-blind, MRI trial of antiherpes therapy in patients with relapsing-remitting multiple sclerosis (RRMS)
    Jakobsen, J
    Bech, E
    Gadeberg, P
    Hansen, HJ
    Christensen, T
    Haahr, S
    Hollsberg, P
    Lycke, J
    Malmestrom, C
    Ekholm, S
    Bergstrom, T
    Svennerholm, B
    Andersen, O
    NEUROLOGY, 2001, 56 (08) : A74 - A74
  • [7] Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial
    Rahimlou, Mehran
    Nematollahi, Shima
    Husain, Durdana
    Banaei-Jahromi, Nasrin
    Majdinasab, Nastaran
    Hosseini, Seyed Ahmad
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [8] Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 9-month double-blind active extension of the multicenter, randomized, double-blind, parallel-group placebo-controlled study
    Comi, Giancarlo
    Abramsky, O.
    Arbizu, T.
    Boyko, Alexey
    Gold, Ralf
    Havrdova, Eva
    Komoly, Samuel
    Selmaj, Krzysztof
    Sharrack, Basil
    Filippi, Massimo
    MULTIPLE SCLEROSIS, 2008, 14 : S37 - S38
  • [9] Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
    Ebers, GC
    Rice, G
    Lesaux, J
    Paty, D
    Oger, J
    Li, DKB
    Beall, S
    Devonshire, V
    Hashimoto, S
    Hooge, J
    Kastrukoff, L
    Krieger, C
    Mezei, M
    Seland, P
    Vorobeychi, G
    Morrison, W
    Nelson, J
    Freedman, MS
    Chrisie, S
    Nelson, R
    Rabinovitch, H
    Freedman, C
    Hartung, HP
    Rieckmann, P
    Archelos, J
    Jung, S
    Weilbach, F
    Flachenecke, P
    Sauer, J
    Hommes, O
    Jongen, P
    Brouwer, S
    McLeod, J
    Pollard, J
    Ng, R
    Sandberg-Wollheim, M
    Källén, K
    Nilsson, P
    Ekberg, R
    Lundgren, A
    Jadbäck, G
    Wikström, J
    Multanen, J
    Valjakka, M
    Carton, H
    Lissoir, F
    Declerq, I
    Vieren, M
    Peeters, E
    Dubois, B
    LANCET, 1998, 352 (9139): : 1498 - 1504
  • [10] Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
    Kappos, Ludwig
    Gold, Ralf
    Miller, David H.
    MacManus, David G.
    Havrdova, Eva
    Limmroth, Volker
    Polman, Chris H.
    Schmierer, Klaus
    Yousry, Tarek A.
    Yang, Minhua
    Eraksoy, Mefkure
    Meluzinova, Eva
    Rektor, Ivan
    Dawson, Katherine T.
    Sandrock, Alfred W.
    O'Neill, Gilmore N.
    LANCET, 2008, 372 (9648): : 1463 - 1472
12345